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Edited by Robert B. RussellAbstract In this paper two competing models of the B-cell lym-
phoma 2 (Bcl-2) apoptotic switch were contrasted by mathemat-
ical modeling and robustness analysis. Since switch-like
behaviors are required for models that attempt to explain the
all-or-none decisions of apoptosis, ultrasensitivity was employed
as a criterion for comparison. Our results successfully exhibit
that the direct activation model operates more reliably to achieve
a robust switch in cellular conditions. Moreover, by investigating
the robustness of other important features of the Bcl-2 apoptotic
switch (including low Bax basal activation, inhibitory role of
anti-apoptotic proteins and insensitivity to small perturbations)
the direct activation model was further supported. In all, we iden-
tiﬁed the direct activation model as a more plausible explanation
for the Bcl-2 apoptotic switch.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Apoptosis is an essential process for multi-cellular organisms
to eliminate unwanted cells in order to achieve tissue remodel-
ing and homeostasis. Robust decision matrixes are required for
cells to conduct all-or-none, irreversible demise in response to
diverse developmental cues or cellular stresses. Dysregulation
of apoptosis contributes to cancer, developmental defects,
autoimmune diseases and certain neurodegenerative disorders
[1,2].
Mitochondria play a central role in apoptosis decisions by
sensing upstream apoptotic signals and responding to them
via mitochondrial outer membrane permeabilization (MOMP)
[2]. MOMP, a rapid all-or-none process, is usually thought to
be a ‘point of no return’ in the mitochondrial apoptosis path-
way [3]. It releases multiple apoptogenic factors such as cyto-
chrome c from the mitochondrial intermembrane space
(IMS) to the cytosol and nucleus, where cellular demolitions
are initiated. MOMP is mainly governed by intricate interac-Abbreviations: Bcl-2, B-cell lymphoma 2; MOMP, mitochondrial outer
membrane permeabilization; IMS, intermembrane space; BH domain,
Bcl-2 homology domain; MAC, mitochondrial apoptosis channel;
ODEs, ordinary diﬀerential equations
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doi:10.1016/j.febslet.2007.09.063tions between three subclasses of the B-cell lymphoma 2
(Bcl-2) protein family [4–10]. Two subclasses promote apopto-
sis: the subfamily of BH3-only proteins (including Bid, Bim,
Puma, Bad, Noxa) sense and integrate cellular damage signals.
Somehow BH3-only proteins activate the subfamily of multi-
domain proteins Bax and Bak, which form mitochondrial
apoptosis channel (MAC) and permeabilize the mitochondrial
outer membrane. This process is opposed by the anti-apoptotic
subclass (Bcl-2, Bcl-xL, Bcl-w, A1 and Mcl-1) which share
sequence conservation through BH1–4. It has been widely
embraced that Bcl-2 protein family constitutes a crucial check-
point in apoptosis [4,5].
Considering the complexity and irreversibility of MOMP,
unrestrained activation of Bax and Bak is supposed to be the
ultimate commitment to cell death [11]. However, exactly
how Bax/Bak activation is regulated is still unclear. Two most
elusive questions are (1) whether multidomain proteins Bax
and Bak are activated directly by BH3-only proteins or not
and (2) in which way do anti-apoptotic proteins exert their
roles to inhibit Bak/Bak activation. Multiple models explain-
ing these questions can be distilled into two distinct ideas,
namely the direct activation model and the indirect activation
model [8,9]. The direct activation model holds that select BH3-
only proteins termed as ‘activators’, including Bim, Bid and,
perhaps, Puma, can directly activate Bax and Bak. Anti-apop-
totic proteins inhibit this process by sequestering activators.
The remaining BH3-only proteins, termed ‘sensitizers’ or ‘ena-
blers’, act only by displacing the activators from the anti-apop-
totic proteins, sensitizing the activation of Bax and Bak. In the
indirect activation model, on the other hand, anti-apoptotic
proteins inhibit apoptosis by sequestering Bax and Bak. All
BH3-only proteins activate Bax or Bak indirectly by binding
and inactivating their speciﬁc anti-apoptotic relatives that con-
strain them. The relative killing potency of diﬀerent BH3-only
proteins is explained based on their relative aﬃnities for anti-
apoptotic partners. Fig. 1 schematically illustrated the struc-
tures of the two models. Recently, compelling new evidence
was reported in support of both models [6,7]. However, prov-
ing which model is more telling by means of experimental ap-
proaches seems diﬃcult thus far [8,9].
Robustness analysis provides an alternative strategy to ex-
ploit the plausibility between diﬀerent models of the biological
system. It has been widely embraced that robustness is a nec-
essary property of biological organisms [12]. The robustness
of certain features of regulatory networks such as adaptations,
oscillations and so on, has been extensively studied [13–20].
Since comparable robustness is required for models that at-
tempt to explain the system, robustness can be employed as
a measure of the quality of a model. This notion has beenblished by Elsevier B.V. All rights reserved.
Fig. 1. Outline of the two models of the Bcl-2 apoptotic switch. (A)
The direct activation model. (B) The indirect activation model.
Rectangles represent molecular species. Arrows represent material
ﬂow. Black line ended with a cycle denotes catalyzed reaction and
those terminated by a bar denote interaction and inhibition.
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ter sensitivities can be used to evaluate the performance of bio-
chemical systems [21]. Morohashi et al. analyzed two models
of the biochemical oscillator, and ﬁrst proposed that paramet-
ric robustness can be regarded as a criterion for determining
plausibility between diﬀerent models [22]. Eissing et al. com-
pared two diﬀerent models of apoptosis signaling by evaluat-
ing their robustness of bistability [23]. They also comparedTable 1
Reactions and parameters of the two models
(A) Reactionsa
Models Reactions k+
Direct activation model Ena + Bcl2  EnaBcl2 k-BH3-B
Act + Bcl2  ActBcl2 k-BH3-B
InBax  Bax k-InBax
n Bax  MAC k-o
Indirect activation model BH3 + Bcl2  BH3Bcl2 k-BH3-B
Bax + Bcl2  BaxBcl2 k-Bax-B
n Bax  MAC k-o
(B) Parametersc
Abbr. Descriptions Valued
[Ena]0 Initial concentration of Ena 2
[Act]0 Initial concentration of Act 1
[BH3]0 Initial concentration of BH3 3
[InBax]0 Initial concentration of InBax 60
[Bcl2]0 Initial concentration of Bcl2 30
k-BH3-Bcl2 Dimerization of BH3and Bcl2 0.0001
kr-BH3Bcl2 Dissociation of BH3-Bcl2dimer 0.001
k-InBax Act-mediated Bax activation 0.001
k-Bax Bax inactivation 0.001
k-Bax-Bcl2 Dimerization of Bax and Bcl2 0.0001
kr-BaxBcl2 Dissociation of Bax-Bcl2 dimer 0.001
k-o Oligomerization of Bax 0.001
kr-o Dissociation of Bax oligomer 0.001
n Cooperative coeﬃcient 4
aAbbreviations used: Ena (Enabler), Act (Activator), BH3 (All BH-3 only pro
Bak pore), Bcl2 (Anti-apoptotics), EnaBcl2 (Enabler–Bcl-2 dimer), ActBcl2
bThe forward reaction (Bax activation) is catalyzed by Act.
cRange: To reﬂect the degree of uncertainty we deﬁned statistical distribution
of variations (0.01–100) around the reference value. The initial concentratio
cooperative coeﬃcient n is assigned a half magnitude of variations.
dUnits: The total amounts of diﬀerent species are expressed in units of nan
second1 and nanomolar1 second1.bistable performances given by three diﬀerent mechanisms in
signal transduction [24,25]. Besides, a variety of methods for
quantifying parametric robustness have been developed recent
years [26,27].
Here, we examined the parametric robustness of the two
models of the Bcl-2 apoptotic switch by numerical simulations.
We mainly focused on whether these two models have ultra-
sensitive responses to apoptotic stimulus. The sensitivities of
the responses were quantiﬁed by estimating the relative ampli-
ﬁcation coeﬃcient, which has been proved more representative
than Hill coeﬃcient [28]. By analyzing the ultrasensitivities of
the two models, we suggested that the direct activation model
operates more reliably to achieve switch-like behavior under
cellular conditions with variations of the internal ‘parameters’.
In addition to ultrasensitivity, the robustness of three other
salient features of the Bcl-2 apoptotic switch, including low
Bax basal activation, inhibitory role of anti-apoptotic proteins
and insensitivity to small perturbations, were investigated. The
results further supported the direct activation model. Thus, the
robustness analysis performed in this study provides a useful
strategy to exploit the plausibility between alternative models
for cellular behaviors and identiﬁed the direct activation model
as a more plausible explanation for the Bcl-2 apoptotic switch.2. Materials and methods
We constructed the two models of the Bcl-2 apoptotic switch pre-
serving the core information of biological events. For example, all
kinds of anti-apoptotic proteins are designated as ‘Bcl2’ despite diﬀer-
ent aﬃnities they have and, ‘Bax’ is used to represent the multidomaink
cl2 kr-BH3Bcl2
cl2 kr-BH3Bcl2
b k-Bax
kr-o
cl2 kr BH3Bcl2
cl2 kr-BaxBcl2
kr-o
Ref. and comment
[29,30]
[29,30]
The sum of [Ena]0 and [Act]0
[29–31]
Estimated from [InBax]0 and the ratio of Bax/Bcl2 [32–34]
[35–37]
[35]
The same as used in [38]
Estimated from k-InBax
The same as k-BH-Bcl2
The same as kr-BH3 Bcl2
Estimated
Estimated
[39]
teins), InBax (Inactive Bax/Bak), Bax (Activated Bax/Bak), MAC (Bax/
(Activator–Bcl-2 dimer), BaxBcl2 (Bax–Bcl-2 dimer).
for each parameter. All the rate constants are assigned four magnitudes
ns of diﬀerent species are assigned one magnitude of variations. The
omolar. The ﬁrst and second rate constants are expressed in units of
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We presented mathematical modeling of the two models with ordinary
diﬀerential equations (ODEs). The law of mass action for biochemical
reactions was used. The reactions and parameters of the two models of
Bcl-2 apoptotic switch are described in Table 1. Details of the kinetic
equations as well as descriptions for the robustness assessment are pre-
sented in Supplement. Diﬀerential equations of our models were solved
mathematically using the ODE23s routine of Matlab 6.5 (The Math-
works Inc., Natick, MA). The evaluation of parametric robustness
was also implemented in Matlab 6.5.3. Results
3.1. Switch-like behaviors of the two models
We ﬁrst examined if the two models with reference parame-
ter sets have ultrasensitive responses to apoptotic stimulus. We
suppose that the concentration of BH3 increases linearly with
the apoptotic stimuli, while details such as expression, degra-
dation and post-translational regulation are not considered
for simplicity:
½BH3 ¼ ½BH30 þ F  ½BH30 ð1Þ
Here, [BH3]0 stands for the initial concentration of BH3; F
stands for the increased folds of [BH3]0 with respect to the in-
put stimuli (F 2 [0,20]).The upper limit of F is set to 20 in our
paper, which means that the concentration of BH3 can have a
maximum 20-fold increase according to the apoptotic stimuli.
For simplicity we regard F as the input stimuli in our analysis.
Similarly, in the direct model we have
½Act ¼ ½Act0 þ F  ½Act0 ð2Þ
½Ena ¼ ½Ena0 þ F  ½Ena0 ð3Þ
Here, [Act]0 and [Ena]0 are the initial concentrations of Activa-
tor and Enabler, respectively. Both Activator and Enabler
simultaneously changed to reﬂect the apoptotic stimuli in
our modeling. For each model with a given stimulus, the stea-
dy-state activity of Bax is assessed as response. It is widely em-
braced that activated Bax is the major component of the
cytochrome c release channel MAC and, in the apoptotic cells,
the amount of oligomeric Bax increases signiﬁcantly [40]. So in
our simulations the percentage of oligomeric Bax to the total
amount of Bax is calculated to indicate the activity of Bax.Fig. 2. The stimulus–response curves and the relative ampliﬁcation plots for t
a function of the input stimuli. (B) For each model the activated fraction f is
ampliﬁcation plot of the two models. Note that the Michaelis–Menten equati
DM: the direct activation model).Fig. 2A shows the stimulus–response curves for the two mod-
els.
The ultrasensitivities of the two curves were quantiﬁed by
two methods. We ﬁrst estimated the Hill coeﬃcients of the
two response curves (Fig. 2B) using the deﬁnition given by
Goldbeter and Koshland [41]. However, high Hill coeﬃcients
(h > 1) here do not suﬃciently imply ultrasensitive responses
since both models have signiﬁcant basal activations (Fig. 2A)
which could make the sensitivity of the responses overesti-
mated. Neither can we tell which response is more ultrasensi-
tive by comparing their Hill coeﬃcients. To circumvent this
problem, the relative ampliﬁcation approach proposed by
Legewie et al. was used [28]. Fig. 2C shows the relative ampli-
ﬁcation plots of the two models. The relative ampliﬁcation
coeﬃcients are estimated for both two models. The values
for the relative ampliﬁcation coeﬃcient of diﬀerent models
have direct biochemical meanings and are comparable to each
other. Our results indicate that none of the two models is ultra-
sensitive, or to say ‘more sensitive than the Michaelis–Menten
equation’. Besides, the direct activation model (with nR =
0.074) seems to be more sensitive than the indirect activation
model (with nR = 0.056).
However, there is still a long way to go before we can tell
which model is more plausible. The reference parameter sets
used here only give a rough estimation of the physiological
conditions and led to a biased calculation. To solve this prob-
lem we have to examine the inﬂuence of parameter variations
on the ultrasensitivities of the two models.
3.2. Parametric robustness of ultrasensitivity
Ultrasensitivity is a key property of the Bcl-2 apoptotic
switch. Thus, comparing the parametric robustness of the
ultrasensitivity can be used as a meaningful discrimination cri-
terion between the two models.
3.2.1. Single parameter changes. In order to study the
inﬂuence of individual parameter changes on the sigmoidality
of the stimulus–response curve, we plot the relative ampliﬁca-
tion coeﬃcient as a function of the single parameter variation
(PV) for each model. Here, the parameter variation is deﬁned
as PV = pi/pi,ref, where pi is the value of the ith parameter of the
model and pi,ref is its corresponding value of the reference set.
Fig. 3 shows the results for both the models of the Bcl-2 apop-
totic switch.he two models. (A) The relative steady-state activity of Bax is plotted as
calculated and plotted as a function of the input stimuli. (C) Relative
on is used as the reference response. (IM: the indirect activation model.
Fig. 3. Relative ampliﬁcation coeﬃcient of the stimulus–response curve in each model as a function of the parameter variation. For comparison
purpose the pairs of parameters employed by both models are plotted in the same subplot, with (A) k-BH3-Bcl2, k-BH3Bcl2 and, (B) k-o, kr-o. The
pairs of parameters speciﬁc to two models ([k-Bax, k-InBax] for the direct activation model and, [k-Bax-Bcl2, k-BaxBcl2] for the indirect activation
model) are plotted in (C). (D) Refers to the changes in the initial concentrations of the Bcl-2 family proteins. Note that [Act]0 and [Ena]0 in the direct
activation model are integrated into [BH3]0 in the indirect activation model. The eﬀect of the cooperative coeﬃcient n is also shown in (D).
Fig. 4. Robustness of ultrasensitivity with respect to global parameter
variations. Note that the grey dotted line in the ﬁgure. Parameter dots
above this line ensure ultrasensitivity of the model. Shown is one
representative result of the three independent simulations.
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[Ena0], [Act0], [Bax0], [Bcl-20], n for the direct activation model,
and k-o, kr-o, [BH30], [Bcl-20], n for the indirect activation
model) have small inﬂuence on ultrasensitivity. This kind of
single parameter insensitivity is usually regarded as robustness
for steady-state systems. However, to prove that a system has
robust ‘dynamical’ function, such as switch-like behavior,
adaption or oscillation, the size of parameter window in which
the model exhibits these behaviors should also be considered.
Here, the size of parameter window in which the model exhib-
its ultrasensitivity (with nR > 1), should be taken as a criterion
for robustness quantiﬁcation. In our results, with variation of
certain parameters (k-BH3-Bcl2, kr-BH3Bcl2, k-Bax and k-In-
Bax), the direct activation model can employ a parameter win-
dow of ultrasensitivity (Fig. 3A and C). However, the indirect
activation model can never show ultrasensitivity even if indi-
vidual parameter is varied in full physiological ranges. This dif-
ference suggests that the direct activation model outperforms
the indirect activation model with respect to robustness in sin-
gle parameter analyses.
3.2.2. Global parameter variations. Cell-to-cell variations
and environmental diﬀerences may lead to multiparametric
uncertainty, which means a group of parameters diﬀer from
their ‘nominal’ values at a time. It is possible that the eﬀects
of diﬀerent parameter variations can compensate or, enforce
each other. We here investigated how systematic parameter
changes inﬂuence the ultrasensitivities of the two models.
To measure robustness we employed the frequency of occur-
rence of ultrasensitive response of the model with 3000 randomparameter sets for each model. Similar to [13,19,20], we plot
for each parameter set the calculated relative ampliﬁcation
coeﬃcient as a function of the total parameter variation TPV
in the scatter plot (Fig. 4). TPV is deﬁned as the total order
of magnitude of parameter variation [13,19,20]:
TPV ¼
Xnpara
i¼1
log10
pi
pi;ref

: ð4Þ
Here, npara is the number of the parameters in each model and
pi and pi,ref are parameters in the test set and reference para-
C. Chen et al. / FEBS Letters 581 (2007) 5143–5150 5147meter set, respectively. Thus, TPV can be envisioned as a mea-
sure for distances in kinetic parameter sets. It can be seen that
the direct activation model has a much larger volume of the
parameter space ensuring ultrasensitivity. We found 996
parameter sets that exhibited ultrasensitive responses (with
nR > 1) for the direct activation model (Fig. 4, grey open cir-
cles, upper the dotted line). However, for the indirect activa-
tion model, the number of parameter sets exhibiting
ultrasensitive response (with nR > 1) is only 217 (Fig. 4, black
ﬁlled dots, upper the dotted line). Therefore, as has a larger
volume of parameter space allowing the switch-like behavior,
the direct activation model confers a better robustness of ultra-
sensitivity with respect to global parameter variations.
3.3. Robustness of other important features
Comparing the ultrasensitivity of Bax activation cannot be
considered complete to discriminate between the two modelsFig. 5. The number of total parameter sets that ensure desired features of the
(B) The indirect activation model. For each model the simulations are repeate
parameters. The mean of three samples in each test is given above the bars. R
anti-apoptotic proteins. Insensitivity Test: insensitivity to small perturbatio
features simultaneously. Combine 2: combination of these three tests with th
Table 2
Three tests for evaluation of other features of the Bcl-2 apoptotic
switcha
Tests Normal Stimuli Stimuli +
protection
Small
perturbation
Range Test <T >T – –
Inhibition Test – >T <T –
Insensitivity Test <T – – <T
All <T >T <T <T
aWe roughly use an increased 15-folds of BH-3 only proteins to mimic
the stimuli, and an increased 15-folds of anti-apoptotics to mimic the
protection experiments. 33.3% of the stimuli were used to test the
model’s insensitivity to small perturbations. A threshold of the relative
activity of Bax (T) is deﬁned here. We used T = 0.5 in our simulations,
which means a half of Bax homo-oligomerized.since there are other important features of the Bcl-2 apoptotic
switch, for example, the inhibitory role of anti-apoptotic
proteins. It has been widely embraced that anti-apoptotics
can inhibit apoptosis by suppressing Bax activation and oligo-
merization. Anti-apoptotics (Bcl-2, Bcl-xL, etc.) overexpress-
ing cells were reported to be apoptosis-resistant, and with
suppressed Bax oligomerization [42]. Besides, in non-apoptotic
cells Bax should predominately exist as inactivated monomers
[11]. Furthermore, cells can preserve low activity of Bax even
with small perturbations of the apoptotic stimuli [43]. To cir-
cumvent such problems we extended the robustness analysis
by posing additional requirements to the models.
Simulations under four diﬀerent initial conditions were per-
formed with 3000 random parameter sets for each model. Cal-
culations were performed to address diﬀerent features of the
Bcl-2 apoptotic switch (Table 2). First, low basal activation
of Bax was checked by the Range Test. We supposed that in
non-apoptotic cells the basal activation level of Bax should be-
low a threshold while with apoptotic stimuli the activity of Bax
should exceed it. The number of parameter sets ensuring this
property was calculated and its relative frequency was used
as a measure of robustness (Fig. 5A and B, Range Test). Sim-
ilarly, the robustness of other two properties can be estimated
(Fig. 5A and B). In Inhibition Test we supposed that with
apoptotic stimuli the activity of Bax should exceed the thresh-
old while it should be reduced back below the threshold when
anti-apoptotic proteins were added. Insensitivity Test means
that the model should preserve low activity of Bax in non-
apoptotic condition and, even with small perturbations of
the apoptotic stimuli. For all these tests, semi-quantitative sim-
ulations were performed since a uniﬁed quantitative model is
not yet practical.Bcl-2 apoptotic switch for each model. (A) The direct activation model.
d using three independent samples, each consisting of 3000 latin sets of
ange Test: low Bax basal activation. Inhibition Test: inhibitory role of
ns. Combine 1: proportion of parameters which can ensure all three
e ultrasensitivity analysis.
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direct activation model is more likely to achieve low basal acti-
vation and employ insensitivity to small perturbations. The
indirect activation model is more likely to achieve the inhibi-
tory role of anti-apoptotic proteins. If all three features are
considered simultaneously, the direct activation model em-
ploys a larger parameter space than the indirect activation
model (Fig. 5A and B, combine 1). Then we combined these
tests with the results of the ultrasensitivity analysis. For the
indirect activation model, we found only 33 out of the 3000
random parameter sets can ensure both these features and
ultrasensitivity. However, 316 out of the 3000 parameter sets
can meet all the requirements (Fig. 5A and B, combine 2) in
the direct activation model. Thus, we concluded that the direct
activation model confers a better robustness in contrast to the
indirect activation model.4. Discussion
Biological signaling networks are complex and diﬃcult to
untangle. Usually, wet lab experiments alone are not of much
help. Contradictory results are reported by diﬀerent groups
based on diﬀerent experimental systems. So it is common to
see that multiple competing models for a regulation are postu-
lated in literature. As a particular example discussed in this pa-
per, two distinct models of the regulation of the Bcl-2 network,
which constitutes a robust switch that regulates apoptosis,
were supported by diﬀerent groups and contradictory evi-
dences [6–9]. Proving which model is more plausible based
on intuitions is not possible because of the complexity of the
system. An alternative strategy to exploit the plausibility be-
tween diﬀerent models of the biological system is mathematical
modeling. It is widely embraced that faithful models should
not rely on ﬁne tuned parameters to reﬂect biological systems.
Thus, determining the robustness of mathematical models can
help distinguish between more and less plausible models, as
has been discussed previously [21–25].
Ultrasensitivity was employed as a ﬁrst criterion for compar-
ison. It was quantiﬁed by estimating the relative ampliﬁcation
coeﬃcient, which has been proved more representative than
Hill coeﬃcient when basal activation is high. Here, the interac-
tions of Bcl-2 family proteins are not typical enzymatic reac-
tions and both models can have high basal activation. In the
direct model, Bax can be activated directly by the initial part
of Activator and thus make up the basal activation. In the
indirect model, Bax can oligomerize spontaneously in non-
apoptotic condition. Thus, in this paper the relative ampliﬁca-
tion approach proposed by Legewie et al. provides a better
choice for us to quantify the ultrasensitivity.
Our results reveal that the direct model is more likely to be
ultrasensitive than the indirect model with parameter varia-
tions. It is mainly due to the diﬀerent regulating mechanisms
of the two models. In the direct model, Bax are activated di-
rectly by Activator before they can oligomerize into pores.
To have ultrasensitive responses, the ability of Activator to
activate Bax should be low (Fig. 3C), or the binding aﬃnity be-
tween Activator and Bcl2 should be high (Fig. 3A). While in
the indirect model, Bax can oligomerize spontaneously. The
reason why Bax do not form pores signiﬁcantly in non-apop-
totic condition is that Bcl2 can sequester most Bax. That re-quires a high binding aﬃnity between Bcl2 and Bax. What is
more, in order to disrupt the binding between Bax and Bcl2,
the binding aﬃnity between BH3 and Bcl2 should also be con-
siderably high. We can ﬁnd that the requirements for the direct
model are more restricted than the direct model. Thus, its nat-
ural that the direct model is more likely to be ultrasensitive
than the indirect model with respect to parameter variations.
We also performed robustness analysis of other important
features of the Bcl-2 apoptotic switch in addition to ultrasensi-
tivity. Single property analysis usually gives limited or even
misleading results. For instance, in our simulations ultrasensi-
tivity does not ensure low basal activation of Bax, which is re-
quired according to experimental observations [11]. So, several
key features of the Bcl-2 regulation network were accounted in
a unifying way, including ultrasensitivity, low basal activation,
anti-apoptotic inhibition and insensitivity to ﬂuctuations.
Ultrasensitivity was quantitatively evaluated by estimating
the relative ampliﬁcation coeﬃcient. Other properties were as-
sessed by evaluating the Boolean output for robustness. Obvi-
ously, such a combined analysis of diﬀerent properties can give
more reasonable results.
Another important question is how to measure the robust-
ness objectively. In tradition, robustness is evaluated by re-
peated simulations varying one or two parameters while
leaving all other ﬁxed. This requires an exact parameter point
in the multidimensional parameter space. However, this partic-
ular ‘point’ is impossible – or at best – diﬃcult to determine.
Instead, statistically distributions of the parameters are more
reasonable to reﬂect the inherent uncertainty of the biological
systems. Moreover, since simultaneous parameter variations
may lead to non-linear eﬀects, it is more important to assess
the robustness with respect to global parameter variations.
To address this question we proposed a Monte Carlo based ap-
proach – sampling parameters from the distributions. The vol-
ume of expected features – such as ultrasensitivity – in the
parameter space was estimated. Then the ratio of the volume
gives comparable results between diﬀerent models. Similar idea
has been applied in [16–18,23,25].
It should be noted that the robustness examined in this pa-
per is only parametric robustness. Other perturbations such
as noise and time delays were not taken into consideration.
Another limitation of this study is that the results of the Monte
Carlo approach are still aﬀected by the parameter ranges we
deﬁned. In our simulations, four magnitudes of variation for
most parameters are allowed thus this eﬀect can be attenuated.
However, it should be expected that more numerically esti-
mated quantities can be made used and therefore less biased
results can be achieved. Finally, there are other hypotheses
of the Bcl-2 regulatory network, including the binding of acti-
vated Bax to anti-apoptotic proteins [8] and Bax/Bak auto-
activation [44]. Indeed, we have revealed in our former study
that when considering the binding of activated Bax to anti-
apoptotic proteins, the direct activation model can show bista-
bility, forming a bio-switch [45]. This is quite interesting. How-
ever, since these hypotheses have not yet been well received, we
mainly focused on the two widely accepted models in this pa-
per.
Notwithstanding these limitations, the parametric robust-
ness analysis performed in this paper successfully selected a
more plausible model from the two competing models of the
Bcl-2 apoptotic switch.
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